1. Home
  2. VRCA vs GLND Comparison

VRCA vs GLND Comparison

Compare VRCA & GLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$3.78

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

GLND

Greenland Energy Company Common Stock

SELL

Current Price

$3.42

Market Cap

101.0M

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
VRCA
GLND
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
88.0M
101.0M
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
VRCA
GLND
Price
$3.78
$3.42
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $13.83
N/A
AVG Volume (30 Days)
44.6K
★ 31.1M
Earning Date
11-13-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $35,577,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$58.01
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 370.22
N/A
52 Week Low
$3.28
$1.09
52 Week High
$9.82
$12.80

Technical Indicators

Market Signals
Indicator
VRCA
GLND
Relative Strength Index (RSI) 35.23 54.55
Support Level N/A $2.60
Resistance Level $5.94 $6.69
Average True Range (ATR) 0.35 0.67
MACD -0.05 -0.10
Stochastic Oscillator 19.48 28.14

Price Performance

Historical Comparison
VRCA
GLND

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About GLND Greenland Energy Company Common Stock

Greenland Energy Co is a Texas energy resources company focused on unlocking Greenland's vast hydrocarbon potential through the application of modern exploration technologies. It holds exclusive licenses to over 2-million acre area in the Jameson Land Basin, where its licenses cover the majority of the basin. The business model for the company is based on exploration and resource development in the frontier basins of Greenland. The company's primary focus is drilling the first wells on the project to conduct the necessary exploration, appraisal and evaluation.

Share on Social Networks: